13 results
10-K
2020 FY
RPTX
Repare Therapeutics Inc
4 Mar 21
Annual report
5:25pm
evidence of an association of a serious hazard with the drug. The FDA also may not approve the inclusion of all labeling claims sought by an applicant
424B4
RPTX
Repare Therapeutics Inc
19 Jun 20
Prospectus supplement with pricing info
4:38pm
there is reasonable evidence of an association of a serious hazard with the drug. The FDA also may not approve the inclusion of all labeling claims
S-1/A
qk4pwaxc
15 Jun 20
IPO registration (amended)
6:18am
S-1/A
EX-10.14
i3fhj
15 Jun 20
IPO registration (amended)
6:18am
S-1
EX-10.14
n42sxeh1wjk3gpkz4akj
29 May 20
IPO registration
5:26pm
S-1
EX-10.12
vdhvg
29 May 20
IPO registration
5:26pm
S-1
lxyqd7h0c4
29 May 20
IPO registration
5:26pm
DRS/A
cbxr7ib2o 7wahdq
12 May 20
Draft registration statement (amended)
12:00am
DRS
EX-10.12
jxwg9rsm6v4w
6 Apr 20
Draft registration statement
12:00am
DRS
bkpf7a8q9b x6
6 Apr 20
Draft registration statement
12:00am
- Prev
- 1
- Next